Latest Prostate-specific antigen Stories
Use of advanced treatment technologies for prostate cancer, such as intensity-modulated radiotherapy and robotic prostatectomy, has increased among men with low-risk disease, high risk of noncancer mortality, or both, a population of patients who are unlikely to benefit from these treatments.
Many men with low-risk, localized prostate cancers can safely choose active surveillance or "watchful waiting" instead of undergoing immediate treatment and have better quality of life while reducing health care costs.
Men’s Cancer Awareness Month in June: Myths about Prostate Cancer Plainview, NY (PRWEB) June 11, 2013 Prostate cancer is the most commonly diagnosed
Researchers recently wrote in the Journal of the American Chemical Society that they have found a safe and inexpensive way to identify clinically usable markers for prostate cancer in urine.
Healthy men under the age of 55 do not need routine annual prostate cancer screenings, according to new clinical practice guidelines released by the American Urological Association (AUA).
Outside the National Cancer Institute, LIJ is one of only two US medical centers to offer new prostate fusion biopsy technology. New Hyde Park, NY (PRWEB) May
- A gift; a largess; a gratuity; a present; a dole.